During the last session, Kintara Therapeutics Inc (NASDAQ:KTRA)’s traded shares were 0.36 million, with the beta value of the company hitting 0.80. The 52-week high for the KTRA share is $4.59, that puts it down -2450.0 from that peak though still a striking 55.56% gain since the share price plummeted to a 52-week low of $0.08. The company’s market capitalization is $9.90M, and the average intraday trading volume over the past 10 days was 1.77 million shares, and the average trade volume was 2.84 million shares over the past three months.
Kintara Therapeutics Inc (KTRA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. KTRA has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Kintara Therapeutics Inc (NASDAQ:KTRA) trade information
Kintara Therapeutics Inc (KTRA) registered a 0.91% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.91% in intraday trading to $0.18, hitting a weekly high. The stock’s 5-day price performance is -15.73%, and it has moved by 11.06% in 30 days. Based on these gigs, the overall price performance for the year is -94.61%. The short interest in Kintara Therapeutics Inc (NASDAQ:KTRA) is 5.43 million shares and it means that shorts have 1.14 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 71.02%.
KTRA Dividends
Kintara Therapeutics Inc is due to release its next quarterly earnings on 2023-Nov-13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Kintara Therapeutics Inc (NASDAQ:KTRA)’s Major holders
Kintara Therapeutics Inc insiders own 0.12% of total outstanding shares while institutional holders control 1.47%, with the float percentage being 1.47%.
